These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21742588)

  • 1. Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations.
    Cunha BA
    J Chemother; 2011 Jun; 23(3):171-4. PubMed ID: 21742588
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline treatment for urinary tract infections: case report and literature review.
    Drekonja DM; Johnson JR
    J Chemother; 2011 Jun; 23(3):168-70. PubMed ID: 21742587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

  • 4. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.
    Guibert J; Destrée D; Konopka C; Acar J
    Eur J Clin Microbiol; 1986 Apr; 5(2):247-8. PubMed ID: 2941292
    [No Abstract]   [Full Text] [Related]  

  • 6. Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.
    Grayson ML; Macesic N; Trevillyan J; Ellis AG; Zeglinski PT; Hewitt NH; Gardiner BJ; Frauman AG
    Clin Infect Dis; 2015 Oct; 61(7):1141-3. PubMed ID: 26063723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection.
    Cunha BA; McDermott B; Nausheen S
    J Chemother; 2007 Dec; 19(6):753-4. PubMed ID: 18230562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lower urinary tract infections in men. Urethritis, cystitis and prostatitis].
    Zanella MC; Schoofs F; Huttner B; Huttner A
    Rev Med Suisse; 2017 Apr; 13(558):808-814. PubMed ID: 28727330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Commentary: Fosfomycin: The Current Status of the Drug.
    Falagas ME; Rafailidis PI
    Clin Infect Dis; 2015 Oct; 61(7):1144-6. PubMed ID: 26063717
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
    de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
    Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.
    Chen A; Smith KP; Whitfield BA; Zucchi PC; Lasco TM; Bias TE; Kirby JE; Hirsch EB
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):365-367. PubMed ID: 28535946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
    de Maio Carrillho CM; Gaudereto JJ; Martins RC; de Castro Lima VA; de Oliveira LM; Urbano MR; Perozin JS; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):253-257. PubMed ID: 27939820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
    Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
    Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of urinary tract infections from multidrug-resistant organisms.
    Gupta K; Bhadelia N
    Infect Dis Clin North Am; 2014 Mar; 28(1):49-59. PubMed ID: 24484574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of using aminoglycoside antibiotics in septicemia and urinary tract infections in newborn infants].
    Sentsova TB; Bombardirova EP; Mamedkulieva DT; Bekmukhambetova ER
    Antibiot Khimioter; 1990 Oct; 35(10):50-2. PubMed ID: 2126174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel case of Raoultella planticola urinary tract infection.
    Olson DS; Asare K; Lyons M; Hofinger DM
    Infection; 2013 Feb; 41(1):259-61. PubMed ID: 22802099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antimicrobial treatment of urinary tract infections and prostatitis.
    Sawyer DW; Mandell GL
    Semin Urol; 1985 Nov; 3(4):281-6. PubMed ID: 3843701
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of phosphonomycin in treatment of urinary-tract infections.
    Barnett JA; Southern PM; Luby JP; Sanford JP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():349-51. PubMed ID: 4918996
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral Fosfomycin and Prostatitis.
    Davido B; Dinh A
    Clin Infect Dis; 2016 Mar; 62(5):671-2. PubMed ID: 26689959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.